[{"indications": "Indications\u00a0maintenance in schizophrenia and other\r\npsychoses", "name": "FLUPHENAZINE DECANOATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.2 Drugs used in psychoses and related disorders", "4.2.2 Antipsychotic depot injections", "FLUPHENAZINE DECANOATE"], "cautions": "Cautions\u00a0see section 4.2.1 and notes above; dose adjustment may be necessary if smoking started or stopped during\r\ntreatment; QT-interval prolongation (avoid concomitant drugs that prolong QT interval)", "side-effects": "Side-effects\u00a0see section 4.2.1 and notes above;\r\nless sedating and fewer antimuscarinic or hypotensive symptoms, but\r\nextrapyramidal symptoms, particularly dystonic reactions and akathisia,\r\nmore frequent; systemic lupus erythematosus, inappropriate antidiuretic\r\nhormone secretion, and oedema also reported; extrapyramidal symptoms\r\nusually appear a few hours after injection and continue for about\r\n2 days but may be delayed", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129235.htm", "doses": ["By deep intramuscular injection into the\r\ngluteal muscle, test dose 12.5\u00a0mg (6.25\u00a0mg in elderly), then after\r\n4\u20137 days 12.5\u2013100\u00a0mg repeated at intervals of 14\u201335 days, adjusted\r\naccording to response; child not recommended"], "pregnancy": "Pregnancy\u00a0see section 4.2.1"}]